Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague

Author： Welkos S.   Pitt M.L.M.   Martinez M.   Friedlander A.   Vogel P.   Tammariello R.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.17, 2002-05, pp. : 2206-2214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse

By Eyles J.E.   Sharp G.J.E.   Williamson E.D.   Spiers I.D.   Alpar H.O.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 698-707

Elsevier

Access to resources Recommend Favorite

The history of the plague and the research on the causative agent Yersinia pestis

By Zietz Björn P.   Dunkelberg Hartmut  

International Journal of Hygiene and Environmental Health, Vol. 207, Iss. 2, 2004-02 ,pp. : 165-178

Urban & Fischer

Access to resources Recommend Favorite

A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model

By Russell P.   Eley S.M.   Hibbs S.E.   Manchee R.J.   Stagg A.J.   Titball R.W.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1551-1556

Elsevier

Access to resources Recommend Favorite

Nonhuman primate models to evaluate vaccine safety and immunogenicity

By Kennedy R.C.   Shearer M.H.   Hildebrand W.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 903-908

Elsevier

Access to resources Recommend Favorite

Vaccination against bubonic and pneumonic plague

By Titball R.W.   Williamson E.D.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4175-4184

Elsevier

Access to resources Recommend Favorite